Loading...
| A14991 | Pages: 280 | Dec 2021 | 244 Views | | |
| Author(s) : Vishal Bharadwaj , Onkar Sumant | Tables: 160 | Charts: 36 |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Hydrocephalus Market
Request Now !Global hydrocephalus market was valued at $6907.5 million in 2020 and is projected to reach $10178.6 million by 2030, registering a CAGR of 4.0% from 2021 to 2030.
The impact of COVID-19 pandemic is expected to remain moderate for the global hydrocephalus market. The companies are facing a setback, owing to the lockdown, which led to a drop in the manufacturing and the patient flow reduced substantially. However, this deleterious impact is expected to be compensated by the increase in demand for advanced programmable shunts for treating hydrocephalic patients worldwide. Likewise, the introduction of disruptive technologies such as “eShunt system” is all set to booster the growth of the hydrocephalus market post-pandemic.
Hydrocephalus is defined as a condition in which the cerebrospinal fluid (CSF) gets accumulated in the brain. It is the abnormal buildup of fluids in the cavities deep within the brain. Hydrocephalus is one of the most common reasons for brain surgery in young children. As per the data published by the Hydrocephalus Organization, hydrocephalus is a neurological disorder that affects 1 out of 770 new-born and 1 out of 100 senior citizens in America. More than 1 million Americans are currently living with this chronic condition. Moreover, in the U.S., every 15 minutes a brain surgery related to hydrocephalus is performed.
Get more information on this report : Request Sample Pages
Growth of the global hydrocephalus market is majorly driven by increase in the prevalence of neurological disorders, such as brain tumors, spinal cord injury, and stroke, are more prone to develop hydrocephalus and drive the growth of the market. Approximately 125,000 people in the U.S. are currently living with cerebrospinal fluid shunts, as per the University of California, Los Angeles Health Organization. Moreover, the National Institute of Neurological Disorders and Stroke, in 2020, stated that 1 to 2 of every 1000 babies is born with hydrocephalus globally. These aforementioned statistics represent the rise in the prevalence of hydrocephalus across the globe.
Get more information on this report : Request Sample Pages
There is an ongoing trend of introducing advanced technology for hydrocephalus market in the developed economies such as the U.S. and Canada and then unveiling it to the rest of the world. For instance, in January 2021, CereVasc, engaged in the development of minimal invasive treatment for neurological disorder, announced the eShunt device which is used as a minimal invasive treatment of hydrocephalus. This propels the demand for advanced technique in the treatment of hydrocephalus which further supplements the growth of the market.
Get more information on this report : Request Sample Pages
However, Shunt infections are serious complications that may lead to irreversible brain injuries, meningitis, prolonged hospital stay, increase in the use of antibiotics, and at times need for further surgeries. Similarly, malfunctions occur, owing to complete or partial blockage of shunts that interfere with their overall function. Therefore, such factors are anticipated to decrease the growth of the global hydrocephalus market during the forecast period.
The hydrocephalus market is segmented on the basis of cause, type, diagnosis, treatment, age and region. On the basis of cause, the market is categorized into congenital hydrocephalus and acquired hydrocephalus. By type, the market is segmented into communicating hydrocephalus and non-communicating hydrocephalus. The communicating hydrocephalus is categorized into normal pressure hydrocephalus, ex-vacuo hydrocephalus. The diagnosis segment is fragmented into CT scan, MRI, and ultrasound. Furthermore, on the basis of treatment, the market is categorized into surgery shunt insertion and ventriculostomy.
Get more information on this report : Request Sample Pages
The age is categorized into Neonate & Pediatrics and Adults. Region-wise, the market is analyzed across North America (the U.S., Canada and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
On the basis of cause, the market is categorized into congenital hydrocephalus and acquired hydrocephalus. The acquired hydrocephalus segment led the market in 2020, and is expected to retain its dominance during the forecast period, owing to increase in neurological disorders and injuries such as intraventricular hemorrhage, stroke, tumor, and several other types of CSF infections can result in the development of hydrocephalic conditions among patients
Get more information on this report : Request Sample Pages
On the basis of type, the market is segmented into communicating hydrocephalus and non-communicating hydrocephalus. The communicating hydrocephalus is categorized into normal pressure hydrocephalus, ex-vacuo hydrocephalus. The diagnosis segment is fragmented into CT scan, MRI, and ultrasound. Furthermore, on the basis of treatment, the market is categorized into surgery shunt insertion and ventriculostomy. The age is categorized into Neonate & Pediatrics and Adults owing to a rise in the incidences of intraventricular hemorrhage or other brain injuries. Furthermore, the surge in incidences of stroke among children and adults, owing to major lifestyle changes & disorders is anticipated to boost the demand for shunts in these age groups.
North America accounted for a major share in the global hydrocephalus market in 2020, and is expected to maintain its dominance during the forecast period, owing to rise in prevalence of neurological disorder, increase in number of hydrocephalus patients, development of advanced healthcare medical devices, and development in technology for hydrocephalus in the region.
Get more information on this report : Request Sample Pages
However, Asia-Pacific is expected to register highest CAGR of 5.0% from 2021 to 2030, owing to increase in geriatric population as they are more prone to neurological disorders, rise in awareness regarding minimally invasive surgeries, surge in cases of stroke and CSF related disorders and technological advances accelerate the growth of the hydrocephalus market during the forecast period.
Key players operating in the global hydrocephalus market include Aesculap Inc., Integra Lifesciences, Karl Storz Se And Co. Kg, Proteses Inc., Medtronic Plc. and Natus Medical Inc. Further, the service provider of hydrocephalus is Boston Children’s Hospital, Anadolu Medical Center, Helios Hospital, Texas Children's Hospital, and Children's National Hospital.
Get more information on this report : Request Sample Pages
Key Market Segments
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.3.1.List of key players profile and Service provider in the report
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Porter’s five forces analysis
3.4.Market dynamics
3.4.1.Drivers
3.4.1.1.Growth in prevalence of hydrocephalus
3.4.1.2.Surge in adoption of hydrocephalus shunt
3.4.1.3.Increase in incidences of neurological disorders
3.4.2.Restraint
3.4.2.1.Shunt malfunction and related infections
3.4.3.Opportunity
3.4.3.1.Advancements in technology in the healthcare sector
3.5.Top player positioning
3.6.Communicating hydrocephalus: Causes, Symptoms, and Treatments
3.7.COVID-19 Impact on the market
CHAPTER 4:HYDROCEPHALUS MARKET, BY CAUSE
4.1.Overview
4.1.1.Market size and forecast
4.2.Congenital Hydrocephalus
4.2.1.Market size and forecast, by region
4.2.2.Market share analysis, by country
4.3.Acquired hydrocephalus
4.3.1.Market size and forecast, by region
4.3.2.Market analysis, by country
CHAPTER 5:HYDROCEPHALUS MARKET, BY TYPE
5.1.Overview
5.1.1.Market size and forecast
5.2.Communicating hydrocephalus
5.2.1.Key market trends and growth opportunities
5.2.2.Market size and forecast, by region
5.2.3.Market analysis, by country
5.2.4.Market size and forecast, by type
5.2.4.1.Normal pressure hydrocephalus
5.2.4.1.1.Market size and forecast
5.2.4.2.Ex-Vacuo hydrocephalus
5.2.4.2.1.Market size and forecast
5.3.Non-communicating hydrocephalus
5.3.1.Key market trends and growth opportunities
5.3.2.Market size and forecast, by region
5.3.3.Market analysis, by country
CHAPTER 6:HYDROCEPHALUS MARKET, BY DIAGNOSIS
6.1.Overview
6.1.1.Market size and forecast
6.2.CT Scan
6.2.1.Market size and forecast, by region
6.2.2.Market share analysis, by country
6.3.MRI
6.3.1.Market size and forecast, by region
6.3.2.Market analysis, by country
6.4.Ultrasound
6.4.1.Market size and forecast, by region
6.4.2.Market analysis, by country
CHAPTER 7:HYDROCEPHALUS MARKET, BY TREATMENT
7.1.Overview
7.1.1.Market size and forecast
7.2.Surgery shunt insertion
7.2.1.Market size and forecast, by region
7.2.2.Market share analysis, by country
7.3.Ventriculostomy
7.3.1.Market size and forecast, by region
7.3.2.Market analysis, by country
CHAPTER 8:HYDROCEPHALUS MARKET, BY AGE
8.1.Overview
8.1.1.Market size and forecast
8.2.Neonate and Pediatrics
8.2.1.Market size and forecast, by region
8.2.2.Market share analysis, by country
8.3.Adults
8.3.1.Market size and forecast, by region
8.3.2.Market analysis, by country
CHAPTER 9:HYDROCEPHALUS MARKET, BY REGION
9.1.Overview
9.1.1.Market size and forecast
9.2.North America
9.2.1.Key market trends, growth factors, and opportunities
9.2.2.North America market size and forecast, by cause
9.2.3.North America market size and forecast, by type
9.2.4.North America market size and forecast, by diagnosis
9.2.5.North America market size and forecast, by treatment
9.2.6.North America market size and forecast, by age
9.2.7.Market size and forecast, by country
9.2.7.1.U.S.
9.2.7.1.1.U.S. Hydrocephalus Market, by cause
9.2.7.1.2.U.S. Hydrocephalus Market, by type
9.2.7.1.3.U.S. Hydrocephalus Market, by diagnosis
9.2.7.1.4.U.S. Hydrocephalus Market, by treatment
9.2.7.1.5.U.S. Hydrocephalus Market, by age
9.2.7.2.Canada
9.2.7.2.1.Canada Hydrocephalus Market, by cause
9.2.7.2.2.Canada Hydrocephalus Market, by type
9.2.7.2.3.Canada Hydrocephalus Market, by diagnosis
9.2.7.2.4.Canada Hydrocephalus Market, by treatment
9.2.7.2.5.Canada Hydrocephalus Market, by age
9.2.7.3.Mexico
9.2.7.3.1.Mexico Hydrocephalus Market, by cause
9.2.7.3.2.Mexico Hydrocephalus Market, by type
9.2.7.3.3.Mexico Hydrocephalus Market, by diagnosis
9.2.7.3.4.Mexico Hydrocephalus Market, by treatment
9.2.7.3.5.Mexico Hydrocephalus Market, by age
9.3.Europe
9.3.1.Key market trends, growth factors, and opportunities
9.3.2.Europe market size and forecast, by cause
9.3.3.Europe market size and forecast, by type
9.3.4.Europe market size and forecast, by diagnosis
9.3.5.Europe market size and forecast, by treatment
9.3.6.Europe market size and forecast, by age
9.3.7.Market size and forecast, by country
9.3.7.1.Germany
9.3.7.1.1.Germany Hydrocephalus Market, by cause
9.3.7.1.2.Germany Hydrocephalus Market, by type
9.3.7.1.3.Germany Hydrocephalus Market, by diagnosis
9.3.7.1.4.Germany Hydrocephalus Market, by treatment
9.3.7.1.5.Germany Hydrocephalus Market, by age
9.3.7.2.France
9.3.7.2.1.France Hydrocephalus Market, by cause
9.3.7.2.2.France Hydrocephalus Market, by type
9.3.7.2.3.France Hydrocephalus Market, by diagnosis
9.3.7.2.4.France Hydrocephalus Market, by treatment
9.3.7.2.5.France Hydrocephalus Market, by age
9.3.7.3.UK
9.3.7.3.1.UK Hydrocephalus Market, by cause
9.3.7.3.2.UK Hydrocephalus Market, by type
9.3.7.3.3.UK Hydrocephalus Market, by diagnosis
9.3.7.3.4.UK Hydrocephalus Market, by treatment
9.3.7.3.5.UK Hydrocephalus Market, by age
9.3.7.4.Italy
9.3.7.4.1.Italy Hydrocephalus Market, by cause
9.3.7.4.2.Italy Hydrocephalus Market, by type
9.3.7.4.3.Italy Hydrocephalus Market, by diagnosis
9.3.7.4.4.Italy Hydrocephalus Market, by treatment
9.3.7.4.5.Italy Hydrocephalus Market, by age
9.3.7.5.Spain
9.3.7.5.1.Spain Hydrocephalus Market, by cause
9.3.7.5.2.Spain Hydrocephalus Market, by type
9.3.7.5.3.Spain Hydrocephalus Market, by diagnosis
9.3.7.5.4.Spain Hydrocephalus Market, by treatment
9.3.7.5.5.Spain Hydrocephalus Market, by age
9.3.7.6.Rest of Europe
9.3.7.6.1.Rest of Europe Hydrocephalus Market, by cause
9.3.7.6.2.Rest of Europe Hydrocephalus Market, by type
9.3.7.6.3.Rest of Europe Hydrocephalus Market, by diagnosis
9.3.7.6.4.Rest of Europe Hydrocephalus Market, by treatment
9.3.7.6.5.Rest of Europe Hydrocephalus Market, by age
9.4.Asia-Pacific
9.4.1.Key market trends, growth factors, and opportunities
9.4.2.Asia-Pacific market size and forecast, by cause
9.4.3.Asia-Pacific market size and forecast, by type
9.4.4.Asia-Pacific market size and forecast, by diagnosis
9.4.5.Asia-Pacific market size and forecast, by treatment
9.4.6.Asia-Pacific market size and forecast, by age
9.4.7.Market size and forecast, by country
9.4.7.1.China
9.4.7.1.1.China Hydrocephalus Market, by Cause
9.4.7.1.2.China Hydrocephalus Market, by type
9.4.7.1.3.China Hydrocephalus Market, by diagnosis
9.4.7.1.4.China Hydrocephalus Market, by treatment
9.4.7.1.5.China Hydrocephalus Market, by age
9.4.7.2.Japan
9.4.7.2.1.Japan Hydrocephalus Market, by cause
9.4.7.2.2.Japan Hydrocephalus Market, by type
9.4.7.2.3.Japan Hydrocephalus Market, by diagnosis
9.4.7.2.4.Japan Hydrocephalus Market, by treatment
9.4.7.2.5.Japan Hydrocephalus Market, by age
9.4.7.3.India
9.4.7.3.1.India Hydrocephalus Market, by cause
9.4.7.3.2.India Hydrocephalus Market, by type
9.4.7.3.3.India Hydrocephalus Market, by diagnosis
9.4.7.3.4.India Hydrocephalus Market, by treatment
9.4.7.3.5.India Hydrocephalus Market, by age
9.4.7.4.Australia
9.4.7.4.1.Australia Hydrocephalus Market, by cause
9.4.7.4.2.Australia Hydrocephalus Market, by type
9.4.7.4.3.Australia Hydrocephalus Market, by diagnosis
9.4.7.4.4.Australia Hydrocephalus Market, by treatment
9.4.7.4.5.Australia Hydrocephalus Market, by age
9.4.7.5.South Korea
9.4.7.5.1.South Korea Hydrocephalus Market, by cause
9.4.7.5.2.South Korea Hydrocephalus Market, by type
9.4.7.5.3.South Korea Hydrocephalus Market, by diagnosis
9.4.7.5.4.South Korea Hydrocephalus Market, by treatment
9.4.7.5.5.South Korea Hydrocephalus Market, by age
9.4.7.6.Rest of Asia-Pacific
9.4.7.6.1.Rest of Asia-Pacific Hydrocephalus Market, by cause
9.4.7.6.2.Rest of Asia-Pacific Hydrocephalus Market, by type
9.4.7.6.3.Rest of Asia-Pacific Hydrocephalus Market, by diagnosis
9.4.7.6.4.Rest of Asia-Pacific Hydrocephalus Market, by treatment
9.4.7.6.5.Rest of Asia-Pacific Hydrocephalus Market, by age
9.5.LAMEA
9.5.1.Key market trends, growth factors, and opportunities
9.5.2.LAMEA market size and forecast, by cause
9.5.3.LAMEA market size and forecast, by type
9.5.4.LAMEA market size and forecast, by diagnosis
9.5.5.LAMEA market size and forecast, by treatment
9.5.6.LAMEA market size and forecast, by age
9.5.7.Market size and forecast, by country
9.5.7.1.Brazil
9.5.7.1.1.Brazil Hydrocephalus Market, by cause
9.5.7.1.2.Brazil Hydrocephalus Market, by type
9.5.7.1.3.Brazil Hydrocephalus Market, by diagnosis
9.5.7.1.4.Brazil Hydrocephalus Market, by treatment
9.5.7.1.5.Brazil Hydrocephalus Market, by age
9.5.7.2.Saudi Arabia
9.5.7.2.1.Saudi Arabia Hydrocephalus Market, by cause
9.5.7.2.2.Saudi Arabia Hydrocephalus Market, by type
9.5.7.2.3.Saudi Arabia Hydrocephalus Market, by diagnosis
9.5.7.2.4.Saudi Arabia Hydrocephalus Market, by treatment
9.5.7.2.5.Saudi Arabia Hydrocephalus Market, by age
9.5.7.3.South Africa
9.5.7.3.1.South Africa Hydrocephalus Market, by cause
9.5.7.3.2.South Africa Hydrocephalus Market, by type
9.5.7.3.3.South Africa Hydrocephalus Market, by diagnosis
9.5.7.3.4.South Africa Hydrocephalus Market, by treatment
9.5.7.3.5.South Africa Hydrocephalus Market, by age
9.5.7.4.Rest of LAMEA
9.5.7.4.1.Rest of LAMEA Hydrocephalus Market, by cause
9.5.7.4.2.Rest of LAMEA Hydrocephalus Market, by type
9.5.7.4.3.Rest of LAMEA Hydrocephalus Market, by diagnosis
9.5.7.4.4.Rest of LAMEA Hydrocephalus Market, by treatment
9.5.7.4.5.Rest of LAMEA Hydrocephalus Market, by age
CHAPTER 10:COMPANY PROFILES
10.1.AESCULAP INC. (B. BRAUN COMPANY)
10.1.1.Company overview
10.1.2.Operating business segments
10.1.3.Product portfolio
10.1.4.Business performance
10.1.5.Key strategic moves and developments
10.2.INTEGRA LIFE SCIENCES INC.
10.2.1.Company overview
10.2.2.Operating business segments
10.2.3.Product portfolio
10.2.4.Business performance
10.2.5.Key strategic moves and developments
10.3.KARL STORZ SE AND CO. KG
10.3.1.Company overview
10.3.2.Operating business segments
10.3.3.Product portfolio
10.4.MEDTRONIC PLC
10.4.1.Company overview
10.4.2.Operating business segments
10.4.3.Product portfolio
10.4.4.Business performance
10.5.NATUS MEDICAL INCORPORATED
10.5.1.Company overview
10.5.2.Company snapshot
10.5.3.Operating business segments
10.5.4.Product portfolio
10.5.5.Business performance
CHAPTER 11:COMPANY PROFILES: SERVICE BASED
11.1.BOSTON CHILDREN’S HOSPITAL
11.1.1.Hospital overview
11.1.2.Hospital snapshot
11.2.ANADOLU MEDICAL CENTER.
11.2.1.Hospital overview
11.2.2.Hospital snapshot
11.3.HELIOS HOSPITAL
11.3.1.Hospital overview
11.3.2.Hospital snapshot
11.4.TEXAS CHILDREN'S HOSPITAL
11.4.1.Hospital overview
11.4.2.Hospital snapshot
11.5.CHILDREN'S NATIONAL HOSPITAL
11.5.1.Hospital overview
11.5.2.Hospital snapshot
LIST OF TABLE
TABLE 01.GLOBAL HYDROCEPHALUS MARKET, BY CAUSE, 2020-2030 ($MILLION)
TABLE 02.CONGENITAL HYDROCEPHALUS MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 03.FOR ACQUIRED HYDROCEPHALUS MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 04.HYDROCEPHALUS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 05.COMMUNICATING HYDROCEPHALUS MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 06.COMMUNICATING HYDROCEPHALUS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 07.NON-COMMUNICATING HYDROCEPHALUS MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 08.GLOBAL HYDROCEPHALUS MARKET, BY DIAGNOSIS, 2020-2030 ($MILLION)
TABLE 09.GLOBAL HYDROCEPHALUS MARKET, BY DIAGNOSIS, 2020-2030 (VOLUME UNITS)
TABLE 10.HYDROCEPHALUS MARKET FOR CT SCAN, BY REGION, 2020-2030 ($MILLION)
TABLE 11.HYDROCEPHALUS MARKET FOR MRI, BY REGION, 2020-2030 ($MILLION)
TABLE 12.HYDROCEPHALUS MARKET FOR HEAD ULTRASOUND, BY REGION, 2020-2030 ($MILLION)
TABLE 13.GLOBAL HYDROCEPHALUS MARKET, BY TREATMENT, 2020-2030 ($MILLION)
TABLE 14.HYDROCEPHALUS MARKET FOR SURGERY SHUNT INSERTION, BY REGION, 2020-2030 ($MILLION)
TABLE 15.HYDROCEPHALUS MARKET FOR VENTRICULOSTOMY, BY REGION, 2020-2030 ($MILLION)
TABLE 16.GLOBAL HYDROCEPHALUS MARKET, BY AGE, 2020-2030 ($MILLION)
TABLE 17.HYDROCEPHALUS MARKET FOR NEONATE AND PEDIATRICS, BY REGION, 2020-2030 ($MILLION)
TABLE 18.HYDROCEPHALUS MARKET FOR VENTRICULOSTOMY, BY REGION, 2020-2030 ($MILLION)
TABLE 19.HYDROCEPHALUS MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 20.NORTH AMERICA HYDROCEPHALUS MARKET, BY CAUSE, 2020–2030 ($MILLION)
TABLE 21.NORTH AMERICA HYDROCEPHALUS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 22.NORTH AMERICA HYDROCEPHALUS MARKET, BY DIAGNOSIS, 2020–2030 ($MILLION)
TABLE 23.NORTH AMERICA HYDROCEPHALUS MARKET, BY TREATMENT, 2020–2030 ($MILLION)
TABLE 24.NORTH AMERICA HYDROCEPHALUS MARKET, BY AGE, 2020–2030 ($MILLION)
TABLE 25.NORTH AMERICA HYDROCEPHALUS MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 26.U.S. HYDROCEPHALUS MARKET, BY CAUSE, 2020–2030 ($MILLION)
TABLE 27.U.S. HYDROCEPHALUS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 28.U.S. HYDROCEPHALUS MARKET, BY DIAGNOSIS, 2020–2030 ($MILLION)
TABLE 29.U.S. HYDROCEPHALUS MARKET, BY TREATMENT, 2020–2030 ($MILLION)
TABLE 30.U.S. HYDROCEPHALUS MARKET, BY AGE, 2020–2030 ($MILLION)
TABLE 31.CANADA HYDROCEPHALUS MARKET, BY CAUSE, 2020–2030 ($MILLION)
TABLE 32.CANADA HYDROCEPHALUS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 33.CANADA HYDROCEPHALUS MARKET, BY DIAGNOSIS, 2020–2030 ($MILLION)
TABLE 34.CANADA HYDROCEPHALUS MARKET, BY TREATMENT, 2020–2030 ($MILLION)
TABLE 35.CANADA HYDROCEPHALUS MARKET, BY AGE, 2020–2030 ($MILLION)
TABLE 36.MEXICO HYDROCEPHALUS MARKET, BY CAUSE, 2020–2030 ($MILLION)
TABLE 37.MEXICO HYDROCEPHALUS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 38.MEXICO HYDROCEPHALUS MARKET, BY DIAGNOSIS, 2020–2030 ($MILLION)
TABLE 39.MEXICO HYDROCEPHALUS MARKET, BY TREATMENT, 2020–2030 ($MILLION)
TABLE 40.MEXICO HYDROCEPHALUS MARKET, BY AGE, 2020–2030 ($MILLION)
TABLE 41.EUROPE HYDROCEPHALUS MARKET, BY CAUSE, 2020–2030 ($MILLION)
TABLE 42.EUROPE HYDROCEPHALUS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 43.EUROPE HYDROCEPHALUS MARKET, BY DIAGNOSIS, 2020–2030 ($MILLION)
TABLE 44.EUROPE HYDROCEPHALUS MARKET, BY TREATMENT, 2020–2030 ($MILLION)
TABLE 45.EUROPE HYDROCEPHALUS MARKET, BY AGE, 2020–2030 ($MILLION)
TABLE 46.EUROPE HYDROCEPHALUS MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 47.GERMANY HYDROCEPHALUS MARKET, BY CAUSE, 2020–2030 ($MILLION)
TABLE 48.GERMANY HYDROCEPHALUS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 49.GERMANY HYDROCEPHALUS MARKET, BY DIAGNOSIS, 2020–2030 ($MILLION)
TABLE 50.GERMANY HYDROCEPHALUS MARKET, BY TREATMENT, 2020–2030 ($MILLION)
TABLE 51.GERMANY HYDROCEPHALUS MARKET, BY AGE, 2020–2030 ($MILLION)
TABLE 52.FRANCE HYDROCEPHALUS MARKET, BY CAUSE, 2020–2030 ($MILLION)
TABLE 53.FRANCE HYDROCEPHALUS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 54.FRANCE HYDROCEPHALUS MARKET, BY DIAGNOSIS, 2020–2030 ($MILLION)
TABLE 55.FRANCE HYDROCEPHALUS MARKET, BY TREATMENT, 2020–2030 ($MILLION)
TABLE 56.FRANCE HYDROCEPHALUS MARKET, BY AGE, 2020–2030 ($MILLION)
TABLE 57.UK HYDROCEPHALUS MARKET, BY CAUSE, 2020–2030 ($MILLION)
TABLE 58.UK HYDROCEPHALUS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 59.UK HYDROCEPHALUS MARKET, BY DIAGNOSIS, 2020–2030 ($MILLION)
TABLE 60.UK HYDROCEPHALUS MARKET, BY TREATMENT, 2020–2030 ($MILLION)
TABLE 61.UK HYDROCEPHALUS MARKET, BY AGE, 2020–2030 ($MILLION)
TABLE 62.ITALY HYDROCEPHALUS MARKET, BY CAUSE, 2020–2030 ($MILLION)
TABLE 63.ITALY HYDROCEPHALUS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 64.ITALY HYDROCEPHALUS MARKET, BY DIAGNOSIS, 2020–2030 ($MILLION)
TABLE 65.ITALY HYDROCEPHALUS MARKET, BY TREATMENT, 2020–2030 ($MILLION)
TABLE 66.ITALY HYDROCEPHALUS MARKET, BY AGE, 2020–2030 ($MILLION)
TABLE 67.SPAIN HYDROCEPHALUS MARKET, BY CAUSE, 2020–2030 ($MILLION)
TABLE 68.SPAIN HYDROCEPHALUS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 69.SPAIN HYDROCEPHALUS MARKET, BY DIAGNOSIS, 2020–2030 ($MILLION)
TABLE 70.SPAIN HYDROCEPHALUS MARKET, BY TREATMENT, 2020–2030 ($MILLION)
TABLE 71.SPAIN HYDROCEPHALUS MARKET, BY AGE, 2020–2030 ($MILLION)
TABLE 72.REST OF EUROPE HYDROCEPHALUS MARKET, BY CAUSE, 2020–2030 ($MILLION)
TABLE 73.REST OF EUROPE HYDROCEPHALUS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 74.REST OF EUROPE HYDROCEPHALUS MARKET, BY DIAGNOSIS, 2020–2030 ($MILLION)
TABLE 75.REST OF EUROPE HYDROCEPHALUS MARKET, BY TREATMENT, 2020–2030 ($MILLION)
TABLE 76.REST OF EUROPE HYDROCEPHALUS MARKET, BY AGE, 2020–2030 ($MILLION)
TABLE 77.ASIA-PACIFIC HYDROCEPHALUS MARKET, BY CAUSE, 2020–2030 ($MILLION)
TABLE 78.ASIA-PACIFIC HYDROCEPHALUS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 79.ASIA-PACIFIC HYDROCEPHALUS MARKET, BY DIAGNOSIS, 2020–2030 ($MILLION)
TABLE 80.ASIA-PACIFIC HYDROCEPHALUS MARKET, BY TREATMENT, 2020–2030 ($MILLION)
TABLE 81.ASIA-PACIFIC HYDROCEPHALUS MARKET, BY AGE, 2020–2030 ($MILLION)
TABLE 82.ASIA-PACIFIC HYDROCEPHALUS MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 83.CHINA HYDROCEPHALUS MARKET, BY CAUSE, 2020–2030 ($MILLION)
TABLE 84.CHINA HYDROCEPHALUS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 85.CHINA HYDROCEPHALUS MARKET, BY DIAGNOSIS, 2020–2030 ($MILLION)
TABLE 86.CHINA HYDROCEPHALUS MARKET, BY TREATMENT, 2020–2030 ($MILLION)
TABLE 87.CHINA HYDROCEPHALUS MARKET, BY AGE, 2020–2030 ($MILLION)
TABLE 88.JAPAN HYDROCEPHALUS MARKET, BY CAUSE, 2020–2030 ($MILLION)
TABLE 89.JAPAN HYDROCEPHALUS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 90.JAPAN HYDROCEPHALUS MARKET, BY DIAGNOSIS, 2020–2030 ($MILLION)
TABLE 91.JAPAN HYDROCEPHALUS MARKET, BY TREATMENT, 2020–2030 ($MILLION)
TABLE 92.JAPAN HYDROCEPHALUS MARKET, BY AGE, 2020–2030 ($MILLION)
TABLE 93.INDIA HYDROCEPHALUS MARKET, BY CAUSE, 2020–2030 ($MILLION)
TABLE 94.INDIA HYDROCEPHALUS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 95.INDIA HYDROCEPHALUS MARKET, BY DIAGNOSIS, 2020–2030 ($MILLION)
TABLE 96.INDIA HYDROCEPHALUS MARKET, BY TREATMENT, 2020–2030 ($MILLION)
TABLE 97.INDIA HYDROCEPHALUS MARKET, BY AGE, 2020–2030 ($MILLION)
TABLE 98.AUSTRALIA HYDROCEPHALUS MARKET, BY CAUSE, 2020–2030 ($MILLION)
TABLE 99.AUSTRALIA HYDROCEPHALUS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 100.AUSTRALIA HYDROCEPHALUS MARKET, BY DIAGNOSIS, 2020–2030 ($MILLION)
TABLE 101.AUSTRALIA HYDROCEPHALUS MARKET, BY TREATMENT, 2020–2030 ($MILLION)
TABLE 102.AUSTRALIA HYDROCEPHALUS MARKET, BY AGE, 2020–2030 ($MILLION)
TABLE 103.SOUTH KOREA HYDROCEPHALUS MARKET, BY CAUSE, 2020–2030 ($MILLION)
TABLE 104.SOUTH KOREA HYDROCEPHALUS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 105.SOUTH KOREA HYDROCEPHALUS MARKET, BY DIAGNOSIS, 2020–2030 ($MILLION)
TABLE 106.SOUTH KOREA HYDROCEPHALUS MARKET, BY TREATMENT, 2020–2030 ($MILLION)
TABLE 107.AUSTRALIA HYDROCEPHALUS MARKET, BY AGE, 2020–2030 ($MILLION)
TABLE 108.REST OF ASIA-PACIFIC HYDROCEPHALUS MARKET, BY CAUSE, 2020–2030 ($MILLION)
TABLE 109.REST OF ASIA-PACIFIC HYDROCEPHALUS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 110.REST OF ASIA-PACIFIC HYDROCEPHALUS MARKET, BY DIAGNOSIS, 2020–2030 ($MILLION)
TABLE 111.REST OF ASIA-PACIFIC HYDROCEPHALUS MARKET, BY TREATMENT, 2020–2030 ($MILLION)
TABLE 112.REST OF ASIA-PACIFIC HYDROCEPHALUS MARKET, BY AGE, 2020–2030 ($MILLION)
TABLE 113.LAMEA HYDROCEPHALUS MARKET, BY CAUSE, 2020–2030 ($MILLION)
TABLE 114.LAMEA HYDROCEPHALUS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 115.LAMEA HYDROCEPHALUS MARKET, BY DIAGNOSIS, 2020–2030 ($MILLION)
TABLE 116.LAMEA HYDROCEPHALUS MARKET, BY TREATMENT, 2020–2030 ($MILLION)
TABLE 117.LAMEA HYDROCEPHALUS MARKET, BY AGE, 2020–2030 ($MILLION)
TABLE 118.LAMEA HYDROCEPHALUS MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 119.BRAZIL HYDROCEPHALUS MARKET, BY CAUSE, 2020–2030 ($MILLION)
TABLE 120.BRAZIL HYDROCEPHALUS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 121.BRAZIL HYDROCEPHALUS MARKET, BY DIAGNOSIS, 2020–2030 ($MILLION)
TABLE 122.BRAZIL HYDROCEPHALUS MARKET, BY TREATMENT, 2020–2030 ($MILLION)
TABLE 123.BRAZIL HYDROCEPHALUS MARKET, BY AGE, 2020–2030 ($MILLION)
TABLE 124.SAUDI ARABIA HYDROCEPHALUS MARKET, BY CAUSE, 2020–2030 ($MILLION)
TABLE 125.SAUDI ARABIA HYDROCEPHALUS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 126.SAUDI ARABIA HYDROCEPHALUS MARKET, BY DIAGNOSIS, 2020–2030 ($MILLION)
TABLE 127.SAUDI ARABIA HYDROCEPHALUS MARKET, BY TREATMENT, 2020–2030 ($MILLION)
TABLE 128.SAUDI ARABIA HYDROCEPHALUS MARKET, BY AGE, 2020–2030 ($MILLION)
TABLE 129.SOUTH AFRICA HYDROCEPHALUS MARKET, BY CAUSE, 2020–2030 ($MILLION)
TABLE 130.SOUTH AFRICA HYDROCEPHALUS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 131.SOUTH AFRICA HYDROCEPHALUS MARKET, BY DIAGNOSIS, 2020–2030 ($MILLION)
TABLE 132.SOUTH AFRICA HYDROCEPHALUS MARKET, BY TREATMENT, 2020–2030 ($MILLION)
TABLE 133.SOUTH AFRICA HYDROCEPHALUS MARKET, BY AGE, 2020–2030 ($MILLION)
TABLE 134.REST OF LAMEA HYDROCEPHALUS MARKET, BY CAUSE, 2020–2030 ($MILLION)
TABLE 135.REST OF LAMEA HYDROCEPHALUS MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 136.BRAZIL HYDROCEPHALUS MARKET, BY DIAGNOSIS, 2020–2030 ($MILLION)
TABLE 137.REST OF LAMEA HYDROCEPHALUS MARKET, BY TREATMENT, 2020–2030 ($MILLION)
TABLE 138.REST OF LAMEA HYDROCEPHALUS MARKET, BY AGE, 2020–2030 ($MILLION)
TABLE 139.AESCULAP (B. BRAUN): COMPANY SNAPSHOT
TABLE 140.AESCULAP (B.BRAUN): OPERATING SEGMENTS
TABLE 141.AESCULAP (B.BRAUN): PRODUCT PORTFOLIO
TABLE 142.AESCULAP (B.BRAUN): KEY DEVELOPMENTS
TABLE 143.INTEGRA: COMPANY SNAPSHOT
TABLE 144.INTEGRA: OPERATING SEGMENTS
TABLE 145.INTEGRA: PRODUCT PORTFOLIO
TABLE 146.INTEGRA: KEY DEVELOPMENTS
TABLE 147.KARL STORZ: COMPANY SNAPSHOT
TABLE 148.KARL STORZ: OPERATING SEGMENTS:
TABLE 149.KARL STORZ: PRODUCT PORTFOLIO
TABLE 150.MEDTRONIC: COMPANY SNAPSHOT
TABLE 151.MEDTRONIC: OPERATING SEGMENTS
TABLE 152.MEDTRONIC: PRODUCT PORTFOLIO
TABLE 153.NATUS MEDICAL: COMPANY SNAPSHOT
TABLE 154.NATUS MEDICAL: OPERATING SEGMENTS
TABLE 155.NATUS MEDICAL: PRODUCT PORTFOLIO
TABLE 156.BOSTON: HOSPITAL SNAPSHOT
TABLE 157.ANADOLU MEDICAL CENTER: HOSPITAL SNAPSHOT
TABLE 158.HELIOS: HOSPITAL SNAPSHOT
TABLE 159.TEXAS CHILDREN'S HOSPITAL: HOSPITAL SNAPSHOT
TABLE 160.CHILDREN’S NATIONAL HOSPITAL: HOSPITAL SNAPSHOT
LIST OF FIGURES
FIGURE 01.HYDROCEPHALUS MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2017–2020*
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENTS, 2017–2020* (%)
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2017–2020*
FIGURE 06.MODERATE BARGAINING POWER OF BUYERS
FIGURE 07.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 08.HIGH THREAT OF NEW ENTRANTS
FIGURE 09.MODERATE THREAT OF SUBSTITUTION
FIGURE 10.MODERATE COMPETITIVE REIVALRY
FIGURE 11.DRIVERS, RESTRAINTS, AND OPPORTUNITY
FIGURE 12.TOP PLAYER POSITIONING, 2020
FIGURE 13.COMPARATIVE ANALYSIS OF CONGENITAL HYDROCEPHALUS MARKET, BY COUNTRY,
2020 & 2030 ($MILLION)
FIGURE 14.COMPARATIVE ANALYSIS OF ACQUIRED HYDROCEPHALUS MARKET, BY COUNTRY,
2020 & 2030 ($MILLION)
FIGURE 15.COMPARATIVE ANALYSIS OF COMMUNICATING HYDROCEPHALUS MARKET, BY COUNTRY,
2020 & 2030 ($MILLION)
FIGURE 16.NORMAL PRESSURE HYDROCEPHALUS, 2020–2030 ($MILLION)
FIGURE 17.COMPARATIVE ANALYSIS OF HYDROCEPHALUS MARKET FOR NON-COMMUNICATING
HYDROCEPHALUS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 18.COMPARATIVE ANALYSIS OF HYDROCEPHALUS MARKET FOR CT SCAN, BY COUNTRY,
2020 & 2030 ($MILLION)
FIGURE 19.COMPARATIVE ANALYSIS OF HYDROCEPHALUS MARKET FOR MRI, BY COUNTRY,
2020 & 2030 ($MILLION)
FIGURE 20.COMPARATIVE ANALYSIS OF HYDROCEPHALUS MARKET FOR HEAD ULTRASOUND, BY COUNTRY,
2020 & 2030 ($MILLION)
FIGURE 21.COMPARATIVE ANALYSIS OF HYDROCEPHALUS MARKET FOR SURGERY SHUNT INSERTION,
BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 22.COMPARATIVE ANALYSIS OF HYDROCEPHALUS MARKET FOR VENTRICULOSTOMY, BY COUNTRY,
2020 & 2030 ($MILLION)
FIGURE 23.COMPARATIVE ANALYSIS OF HYDROCEPHALUS MARKET FOR NEONATE AND PEDIATRICS,
BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 24.COMPARATIVE ANALYSIS OF HYDROCEPHALUS MARKET FOR ADULTS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 25.B. BRAUN: NET SALES, 2018–2020 ($MILLION)
FIGURE 26.B. BRAUN: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 27.B. BRAUN: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 28.INTEGRA: NET SALES, 2018–2020 ($MILLION)
FIGURE 29.INTEGRA: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 30.INTEGRA: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 31.MEDTRONIC: NET SALES, 2018–2020 ($MILLION)
FIGURE 32.MEDTRONIC: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 33.MEDTRONIC: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 34.NATUS MEDICAL: NET SALES, 2018–2020 ($MILLION)
FIGURE 35.NATUS MEDICAL: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 36.NATUS MEDICAL: REVENUE SHARE, BY REGION, 2020 (%)
According to analyst perspective, the hydrocephalus market is expected to witness a steady growth in the future. The market has drawn the interest of the healthcare industry owing to increase in the prevalence of hydrocephalus among individuals has subsequently raised the adoption of shunts, owing to their ability to channel excess fluid from the brain to other parts of the body, which reduces pressure within the brain.
The occurrence of hydrocephalus is expected to increase in coming years, owing to a rise in the incidences of intraventricular hemorrhage or other brain injuries. Furthermore, the surge in incidences of stroke among children and adults, owing to major lifestyle changes & disorders is anticipated to boost the demand for shunts in these age groups.
Furthermore, the market is projected to gain traction in developed regions of North America and Europe during the forecast period. Advanced healthcare infrastructure, a larger pool of patients, increase in disposable income, awareness about hydrocephalic conditions, and availability of shunts used in surgical treatments are estimated to drive the market growth in North America and Europe.
A. The total market value of global hydrocephalus market is $6907.5 million in 2020.
A. The forecast period in the report is from 2021 to 2030.
A. The market value of hydrocephalus market in 2030 is $10178.6 million.
A. The base year for the report is 2020.
A. Yes, hydrocephalus market companies are profiled in the report
A. The top companies that hold the market share in global hydrocephalus market are Aesculap Inc., Integra Lifesciences, Karl Storz Se And Co. Kg, Proteses Inc., Medtronic Plc. and Natus Medical Inc.
A. There is no value chain analysis provided in the hydrocephalus market report.
A. The key trends in the hydrocephalus market are due to the increase in neurological disorders and the chances of developing hydrocephalus condition, leading to a higher demand for advanced shunts for treating hydrocephalus, thereby, contributing toward the market growth.
Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Buy Now *Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
